Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,022 | 16,113 | -10,787 | -10,650 | -23,173 |
| Depreciation Amortization | 2,373 | 9,355 | 6,926 | 4,514 | 2,235 |
| Income taxes - deferred | 6,944 | 20,188 | 11,937 | 3,129 | 2,879 |
| Accounts receivable | 30,501 | -34,873 | -9,705 | -7,937 | 27,350 |
| Accounts payable and accrued liabilities | -1,988 | 2,510 | -278 | -1,143 | -736 |
| Other Working Capital | 12,763 | -46,481 | -45,555 | -34,757 | -10,210 |
| Other Operating Activity | -28,731 | 45,373 | 22,716 | 17,436 | -21,068 |
| Operating Cash Flow | $13,840 | $12,185 | $-24,746 | $-29,408 | $-22,723 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,966 | 63 | -1,470 | -3,019 | -4,309 |
| PPE Investments | -10,564 | -54,026 | -34,153 | -16,795 | -8,432 |
| Investing Cash Flow | $-8,598 | $-53,963 | $-35,623 | $-19,814 | $-12,741 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,621 | 27,522 | 21,298 | N/A | 0 |
| Debt Repayment | -8,203 | -15,494 | -14,931 | -8,123 | -842 |
| Common Stock Issued | 242 | 10,026 | 8,836 | 8,695 | 4,198 |
| Other Financing Activity | -410 | -5,395 | 1,502 | 1,786 | 39 |
| Financing Cash Flow | $1,250 | $16,659 | $16,705 | $2,358 | $3,395 |
| Exchange Rate Effect | 32 | 1 | -9 | -61 | -25 |
| Beginning Cash Position | 143,901 | 169,019 | 169,019 | 169,019 | 169,019 |
| End Cash Position | 150,425 | 143,901 | 125,346 | 122,094 | 136,925 |
| Net Cash Flow | $6,524 | $-25,118 | $-43,673 | $-46,925 | $-32,094 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,840 | 12,185 | -24,746 | -29,408 | -22,723 |
| Capital Expenditure | -22,329 | -54,026 | -34,153 | -16,795 | -8,432 |
| Free Cash Flow | -8,489 | -41,841 | -58,899 | -46,203 | -31,155 |